Clinical, Biochemical, Radiological, Genetic and Therapeutic Analysis of Patients with COMP Gene Variants
- 28 October 2021
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 110 (3) , 313-323
Abstract
Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia type 1 (MED1) are two rare skeletal disorders caused by cartilage oligomeric matrix protein (COMP) variants. This study aims to analyze the genotype and phenotype of patients with COMP variants. Clinical information for 14 probands was collected; DNA was extracted from blood for COMP variant detection. Clinical manifestations and radiology scoring systems were established to evaluate the severity of each patient’s condition. Serum COMP levels in PSACH patients and healthy subjects were measured. Thirty-nine patients were included, along with 12 PSACH probands and two MED1 probands. Disproportionate short stature, waddling gait, early-onset osteoarthritis and skeletal deformities were the most common features. The height Z-score of PSACH patients correlated negatively with age at evaluation (r = − 0.603, p = 0.01) and the clinical manifestation score (r = − 0.556, p = 0.039). Over 50% of the PSACH patients were overweight/obese. The median serum COMP level in PSACH patients was 16.75 ng/ml, which was significantly lower than that in healthy controls (98.53 ng/ml; p < 0.001). The condition of MED1 patients was better than that of PSACH patients. Four novel variants of COMP were detected: c.874T>C, c.1123_1134del, c.1531G>A, and c.1576G>T. Height Z-scores and serum COMP levels were significantly lower in patients carrying mutations located in calmodulin-like domains 6, 7, and 8. As the two phenotypes overlap to different degrees, PSACH and MED1 are suggested to combine to produce “spondyloepiphyseal dysplasia, COMP type”. Clinical manifestations and radiology scoring systems, serum COMP levels and genotype are important for evaluating patient condition severity.Keywords
Funding Information
- National Natural Science Foundation of China (81900811, 81170805, 81670714)
- Chinese Academy of Medical Sciences-CAMS Innovation Fund for Medical Sciences (CAMS-2016-12M-3-003)
This publication has 41 references indexed in Scilit:
- Chop (Ddit3) Is Essential for D469del-COMP Retention and Cell Death in Chondrocytes in an Inducible Transgenic Mouse Model of PseudoachondroplasiaThe American Journal of Pathology, 2012
- Pseudoachondroplasia and multiple epiphyseal dysplasia: A 7‐year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contributionHuman Mutation, 2011
- An Inducible Cartilage Oligomeric Matrix Protein Mouse Model Recapitulates Human Pseudoachondroplasia PhenotypeThe American Journal of Pathology, 2009
- The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin bindingThe FASEB Journal, 2009
- Interaction of Cartilage Oligomeric Matrix Protein/Thrombospondin 5 with AggrecanJournal of Biological Chemistry, 2007
- Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMPHuman Molecular Genetics, 2007
- Role of TSP-5/COMP in PseudoachondroplasiaThe International Journal of Biochemistry & Cell Biology, 2004
- Efficacy of growth hormone therapy for patients with skeletal dysplasiaJournal of Bone and Mineral Metabolism, 2003
- Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasiaHuman Genetics, 2003
- Disease-causing Mutations in Cartilage Oligomeric Matrix Protein Cause an Unstructured Ca2+ Binding DomainJournal of Biological Chemistry, 2002